Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Turnidge

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Antimicrobial Agents and Chemotherapy|August 9, 2021
Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent <i>Candida</i> spp. to Triazoles and Amphotericin B and Aspergillus spp. to Caspofungin: Further Assessment of Modal VariabilityA Espinel-Ingroff, M Sasso, J Turnidge, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and AustraliaD M Livermore, M W Carter, S Bagel, et al.
Antimicrobial Agents and Chemotherapy|September 11, 2013
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?A Espinel-Ingroff, M C Arendrup, M A Pfaller, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2018
Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of <i>cyp51A</i> Mutations on Estimation of Epidemiological Cutoff ValuesA Espinel-Ingroff, J Turnidge, A Alastruey-Izquierdo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 5, 2016
Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definitionP N A Harris, J F McNamara, D C Lye, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazoleA Espinel-Ingroff, A I Aller, E Canton, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2017
Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular MethodsA Espinel-Ingroff, D P B Abreu, R Almeida-Paes, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2018
Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in <i>Candida</i> and <i>Aspergillus</i> Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion MethodsA Espinel-Ingroff, J Turnidge, A Alastruey-Izquierdo, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2015
Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric methodA Espinel-Ingroff, M Alvarez-Fernandez, E Cantón, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Antimicrobial Agents and Chemotherapy|August 9, 2021
Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent <i>Candida</i> spp. to Triazoles and Amphotericin B and Aspergillus spp. to Caspofungin: Further Assessment of Modal VariabilityA Espinel-Ingroff, M Sasso, J Turnidge, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and AustraliaD M Livermore, M W Carter, S Bagel, et al.
Antimicrobial Agents and Chemotherapy|September 11, 2013
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?A Espinel-Ingroff, M C Arendrup, M A Pfaller, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2018
Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of <i>cyp51A</i> Mutations on Estimation of Epidemiological Cutoff ValuesA Espinel-Ingroff, J Turnidge, A Alastruey-Izquierdo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 5, 2016
Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definitionP N A Harris, J F McNamara, D C Lye, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazoleA Espinel-Ingroff, A I Aller, E Canton, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2017
Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular MethodsA Espinel-Ingroff, D P B Abreu, R Almeida-Paes, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2018
Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in <i>Candida</i> and <i>Aspergillus</i> Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion MethodsA Espinel-Ingroff, J Turnidge, A Alastruey-Izquierdo, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2015
Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric methodA Espinel-Ingroff, M Alvarez-Fernandez, E Cantón, et al.
Pageof 7